Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmission

Table 8 Assessment of treatment coverage during mass drug administration (MDA) 1-6

MDA no.	Time of MDA	Reported coverage for the district in%*	Surveyed coverage in%
			Community study^#	School study^§
1	Oct-04	80.0	82.3	80.0
2	Feb-06	95.0	79.0	68.2
3	May-07	87.0	69.9	61.2
4	Feb-09	96.6	66.8	32.9
5	Nov-09	98.7	86.4	43.1
6	Dec-10	75.0	67.9	50.3

* Official NLFEP coverage for eligible individuals in Tanga District, where the three study villages and ten study schools are located.
^# Assessed by interviews shortly after each MDA in the study communities (975, 1009, 883, 930, 778 and 1462 individuals aged ≥ 5 years interviewed after MDA 1-6, respectively).
^§ Assessed by interviews shortly after each MDA in the 10 study schools (859, 676, 776, 836, 704 and 746 Standard 1 pupils interviewed after MDA 1-6, respectively).

ISSN: 1471-2334